Published in J Neurol Neurosurg Psychiatry on August 01, 2001
Peripheral neuropathy. BMJ (2002) 1.56
Neuropathy associated with gluten sensitivity. J Neurol Neurosurg Psychiatry (2006) 1.16
Mechanisms of distal axonal degeneration in peripheral neuropathies. Neurosci Lett (2015) 1.00
Effect of age on the fractional anisotropy (FA) value of peripheral nerves and clinical significance of the age-corrected FA value for evaluating polyneuropathies. Neuroradiology (2011) 0.86
Diagnostic approach to peripheral neuropathy. Ann Indian Acad Neurol (2008) 0.84
How to get the most out of nerve conduction studies and electromyography. J Neurol Neurosurg Psychiatry (2005) 0.83
Causal inference regarding infectious aetiology of chronic conditions: a systematic review. PLoS One (2013) 0.82
The epidemiology and risk factors of chronic polyneuropathy. Eur J Epidemiol (2015) 0.81
Updates in diabetic peripheral neuropathy. F1000Res (2016) 0.81
Chronic idiopathic axonal polyneuropathy revisited. J Neurol (2004) 0.80
Additional causes for distal sensory polyneuropathy in diabetic patients. J Neurol Neurosurg Psychiatry (2006) 0.78
Feasibility and cost efficiency of a diagnostic guideline for chronic polyneuropathy: a prospective implementation study. J Neurol Neurosurg Psychiatry (2006) 0.76
Burning feet in polycythemia vera - peripheral sensorimotor axonal neuropathy with erythromelalgia. Int J Gen Med (2015) 0.75
Are human peripheral nerves sensitive to X-ray imaging? PLoS One (2015) 0.75
Diagnosis of chronic peripheral neuropathy. J Neurol Neurosurg Psychiatry (2001) 0.75
Nerve Conduction Study on Sural Nerve among Nepalese Tailors Using Mechanical Sewing Machine. J Clin Diagn Res (2017) 0.75
Vibration upshot of operating mechanical sewing machine: an insight into common peroneal nerve conduction study. Ann Occup Environ Med (2017) 0.75
My legs are getting old: sinvastatin-induced polyneuropathy. BMJ Case Rep (2011) 0.75
Electrodiagnostic tests are unlikely to change management in those with a known cause of typical distal symmetric polyneuropathy. Muscle Nerve (2017) 0.75
AAEM minimonograph #34: polyneuropathy: classification by nerve conduction studies and electromyography. Muscle Nerve (1990) 2.41
Intensive evaluation of referred unclassified neuropathies yields improved diagnosis. Ann Neurol (1981) 2.36
Ten steps in characterizing and diagnosing patients with peripheral neuropathy. Neurology (1996) 2.24
Investigation of peripheral neuropathy. J Neurol Neurosurg Psychiatry (1995) 1.94
Chronic idiopathic polyneuropathy presenting in middle or old age: a clinical and electrophysiological study of 75 patients. J Neurol Neurosurg Psychiatry (1993) 1.67
Sjögren's syndrome in patients with chronic idiopathic axonal polyneuropathy. J Neurol Neurosurg Psychiatry (1997) 1.54
Chronic polyneuropathy of undetermined cause. J Neurol Neurosurg Psychiatry (1984) 1.51
Chronic idiopathic axonal polyneuropathy: a five year follow up. J Neurol Neurosurg Psychiatry (1994) 1.29
Comparison of electrodiagnostic criteria for primary demyelination in chronic polyneuropathy. Muscle Nerve (1991) 1.11
Diagnostic value of sural nerve biopsy in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry (1998) 1.00
Sensory neuropathies including painful and toxic neuropathies. J Neurol (1997) 0.96
Polymyositis: an overdiagnosed entity. Neurology (2003) 4.36
Nimodipine in animal model experiments of focal cerebral ischemia: a systematic review. Stroke (2001) 3.90
Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: a cohort study. Lancet (2005) 3.46
High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study. Neurology (1990) 3.05
Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke (2005) 2.69
Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine. Lancet (1998) 2.67
Injection with methylprednisolone proximal to the carpal tunnel: randomised double blind trial. BMJ (1999) 2.57
Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). Hum Mol Genet (2000) 2.52
Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review. Neurology (1998) 2.39
Deletions of the survival motor neuron gene in unaffected siblings of patients with spinal muscular atrophy. Am J Hum Genet (1995) 2.33
Outcome in patients with subarachnoid haemorrhage and negative angiography according to pattern of haemorrhage on computed tomography. Lancet (1991) 2.30
Perimesencephalic hemorrhage: a nonaneurysmal and benign form of subarachnoid hemorrhage. Neurology (1985) 2.18
Low frequency of neurosyphilis in HIV-infected individuals. Lancet (1993) 2.09
Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (2007) 2.08
Identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease type 1A. Nat Genet (1992) 2.04
[Prion disease: a new class of neurodegenerative disorders]. Ned Tijdschr Geneeskd (1995) 2.02
[Measuring the functional status of patients in clinical trials using modern clinimetric methods]. Ned Tijdschr Geneeskd (2002) 2.01
The clinical course of perimesencephalic nonaneurysmal subarachnoid hemorrhage. Ann Neurol (1991) 1.89
Acute hydrocephalus after aneurysmal subarachnoid hemorrhage. J Neurosurg (1985) 1.87
Paraplegin mutations in sporadic adult-onset upper motor neuron syndromes. Neurology (2008) 1.86
Grading the amount of blood on computed tomograms after subarachnoid hemorrhage. Stroke (1990) 1.83
Phenotype of Charcot-Marie-Tooth disease Type 2. Neurology (2007) 1.79
Fatal ischaemic brain oedema after early thrombolysis with tissue plasminogen activator in acute stroke. BMJ (1988) 1.76
International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009. Vox Sang (2011) 1.69
Increasing cerebrospinal fluid chemokine concentrations despite undetectable cerebrospinal fluid HIV RNA in HIV-1-infected patients receiving antiretroviral therapy. J Acquir Immune Defic Syndr (2000) 1.68
[Creative mathematics with clopidogrel; exaggeration of the preventive effect by manufacturer]. Ned Tijdschr Geneeskd (1999) 1.68
Diagnostic criteria for Duchenne and Becker muscular dystrophy and myotonic dystrophy. Neuromuscul Disord (1991) 1.68
Chronic idiopathic polyneuropathy presenting in middle or old age: a clinical and electrophysiological study of 75 patients. J Neurol Neurosurg Psychiatry (1993) 1.67
Plasma and gamma-globulin infusion in chronic inflammatory polyneuropathy. J Neurol Sci (1985) 1.67
Response to cytarabine in progressive multifocal leucoencephalopathy in AIDS. Lancet (1991) 1.62
Survival in SMA type I: a prospective analysis of 34 consecutive cases. Neuromuscul Disord (2008) 1.60
Epidemiology of inclusion body myositis in the Netherlands: a nationwide study. Neurology (2000) 1.57
[Interferon beta-1b now also for the secondary progressive form of multiple sclerosis?]. Ned Tijdschr Geneeskd (1999) 1.56
Multifocal inflammatory demyelinating neuropathy: a distinct clinical entity? Neurology (2000) 1.54
Prediction of delayed cerebral ischemia, rebleeding, and outcome after aneurysmal subarachnoid hemorrhage. Stroke (1988) 1.52
Ganciclovir/foscarnet for cytomegalovirus meningoencephalitis in AIDS. Lancet (1992) 1.50
The postpolio syndrome: no evidence for poliovirus persistence. Ann Neurol (1992) 1.48
Type VI collagen mutations in Bethlem myopathy, an autosomal dominant myopathy with contractures. Nat Genet (1996) 1.47
Antifibrinolytic treatment in subarachnoid hemorrhage. N Engl J Med (1984) 1.46
Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in The Netherlands: a cohort study. Lancet (1999) 1.46
Injection with methylprednisolone in patients with the carpal tunnel syndrome: a randomised double blind trial testing three different doses. J Neurol (2005) 1.45
Serial electrocardiographic recording in aneurysmal subarachnoid hemorrhage. Stroke (1989) 1.44
Hyponatremia and cerebral infarction in patients with ruptured intracranial aneurysms: is fluid restriction harmful? Ann Neurol (1985) 1.44
Treatment of respiratory impairment in patients with motor neuron disease in the Netherlands: patient preference and timing of referral. Eur J Neurol (2013) 1.43
Clinical characterisation of Becker muscular dystrophy patients predicts favourable outcome in exon-skipping therapy. J Neurol Neurosurg Psychiatry (2013) 1.42
[Conversion disorder: from DSM IV to DSM 5 or from a psychiatric to a neurological diagnosis]. Tijdschr Psychiatr (2015) 1.42
[Confusion and abnormal liver enzyme levels: problems with diagnosing hepatic encephalopathy]. Ned Tijdschr Geneeskd (2007) 1.40
Dysphagia in postpolio patients: a videofluorographic follow-up study. Dysphagia (1994) 1.40
[Medicinal treatment of Bell's palsy: effect of prednisolone not sufficiently demonstrated]. Ned Tijdschr Geneeskd (2008) 1.39
[Supplemental treatment of bacterial meningitis with corticosteroids still insufficiently founded]. Ned Tijdschr Geneeskd (1994) 1.39
[Pharmacological treatment of Bell's palsy: favourable effects of prednisolone-based therapy now demonstrated]. Ned Tijdschr Geneeskd (2008) 1.39
Rapid determination of the hypoxanthine increase in ischemic exercise tests. Clin Chem (1988) 1.38
[Cerebrospinal fluid diagnosis using polymerase chain reaction]. Ned Tijdschr Geneeskd (1996) 1.38
Nonaneurysmal perimesencephalic subarachnoid hemorrhage: CT and MR patterns that differ from aneurysmal rupture. AJNR Am J Neuroradiol (1991) 1.38
Patterns of conduction failure in the Guillain-Barré syndrome. Brain (1988) 1.38
[Pain in one leg in patients with cancer]. Ned Tijdschr Geneeskd (1998) 1.38
[Transient ischemic attacks, non-invalidating brain infarcts and the prevention of worse: current findings on its treatment]. Ned Tijdschr Geneeskd (1991) 1.37
Increased peroxynitrite activity in AIDS dementia complex: implications for the neuropathogenesis of HIV-1 infection. J Immunol (1999) 1.34
Activities of daily living instruments:optimizing scales for neurologic assessments. Neurology (2003) 1.32
Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy. Neuromuscul Disord (1999) 1.32
Calpainopathy-a survey of mutations and polymorphisms. Am J Hum Genet (1999) 1.31
Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study. J Neurol Neurosurg Psychiatry (1995) 1.31
Redefining the clinical phenotypes of non-dystrophic myotonic syndromes. J Neurol Neurosurg Psychiatry (2009) 1.29
Antiretroviral drugs and the central nervous system. AIDS (1998) 1.28
Timing of surgery in patients with aneurysmal subarachnoid haemorrhage: rebleeding is still the major cause of poor outcome in neurosurgical units that aim at early surgery. J Neurol Neurosurg Psychiatry (1997) 1.28
Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir. AIDS (2000) 1.26
Complications and outcome in patients with aneurysmal subarachnoid haemorrhage: a prospective hospital based cohort study in the Netherlands. J Neurol Neurosurg Psychiatry (2000) 1.26
Connexin32 gene mutations in X-linked dominant Charcot-Marie-Tooth disease (CMTX1). Hum Genet (1997) 1.26
Management problems in acute hydrocephalus after subarachnoid hemorrhage. Stroke (1989) 1.26
Multidisciplinary ALS care improves quality of life in patients with ALS. Neurology (2005) 1.26
EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol (2008) 1.25
Successful autologous stem cell transplantation in a patient with chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry (2002) 1.25
Epicardial and endocardial mapping of ventricular tachycardia in patients with myocardial infarction. Is the origin of the tachycardia always subendocardially localized? Circulation (1991) 1.25
Bethlem myopathy: a slowly progressive congenital muscular dystrophy with contractures. Brain (1999) 1.24
Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy. Clinical and laboratory characteristics associated with improvement. Arch Neurol (1991) 1.24
Lamin A/C mutations with lipodystrophy, cardiac abnormalities, and muscular dystrophy. Neurology (2002) 1.23
Long-term outcome in polymyositis and dermatomyositis. Ann Rheum Dis (2006) 1.22
Sporadic lower motor neuron disease with adult onset: classification of subtypes. Brain (2003) 1.22
What should be defined as good outcome in stroke trials; a modified Rankin score of 0-1 or 0-2? J Neurol (2008) 1.21
Intravenous immunoglobulin for multifocal motor neuropathy. Cochrane Database Syst Rev (2005) 1.20
EFNS guideline on diagnosis and management of limb girdle muscular dystrophies. Eur J Neurol (2007) 1.20
EFNS guideline on diagnosis and management of post-polio syndrome. Report of an EFNS task force. Eur J Neurol (2006) 1.20
The temperature-sensitive bond in human alpha 2-macroglobulin is the alkylamine-reactive site. J Biol Chem (1980) 1.18
Deletion of the serine 34 codon from the major peripheral myelin protein P0 gene in Charcot-Marie-Tooth disease type 1B. Nat Genet (1993) 1.17
The Lambert-Eaton myasthenic syndrome 1988-2008: a clinical picture in 97 patients. J Neuroimmunol (2008) 1.16
Volume depletion and natriuresis in patients with a ruptured intracranial aneurysm. Ann Neurol (1985) 1.16
Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir/saquinavir or ritonavir/saquinavir/stavudine. AIDS (2000) 1.16
Laing early onset distal myopathy: slow myosin defect with variable abnormalities on muscle biopsy. J Neurol Neurosurg Psychiatry (2005) 1.16
Charcot-Marie-Tooth disease due to a de novo mutation of the RAB7 gene. Neurology (2006) 1.15
The unfolding clinical spectrum of POLG mutations. J Med Genet (2009) 1.14
Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (2005) 1.13
Mutation analysis of the entire mitochondrial genome using denaturing high performance liquid chromatography. Nucleic Acids Res (2000) 1.12
The AMC Linear Disability Score in patients with newly diagnosed Parkinson disease. Neurology (2007) 1.12
Chronic inflammatory demyelinating polyneuropathy. Conduction failure before and during immunoglobulin or plasma therapy. Brain (1989) 1.11
Degenerative cervical radiculopathy: diagnosis and conservative treatment. A review. Eur J Neurol (2009) 1.11
Necrotising myopathy, an unusual presentation of a steroid-responsive myopathy. J Neurol (2003) 1.11
The Mad1-Sin3B interaction involves a novel helical fold. Nat Struct Biol (2000) 1.11
Delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: clinicoanatomic correlations. Neurology (1986) 1.10
Standardised pre-hospital care of acute myocardial infarction patients: MISSION! guidelines applied in practice. Neth Heart J (2010) 1.10